Pharmafile Logo
Pharmafocus logo
Advanced Search
humira_abbott_

Top 10 medicines issued in England by prescription cost in 2014-15

March 2, 2016
Research and Development, Sales and Marketing Cost, Humira, NHS, prescription

AbbVie, Humira (adalimumab), £371m. This drug treats a variety of conditions including psoriatic arthritics, Crohn’s disease and ulcerative colitis. The …

Feature
hilary_clinton_speaks_at_a_rally_in_des_moines_in_january

Clinton steps up attacks on Valeant in latest campaign advert

March 2, 2016
Research and Development, Sales and Marketing Hilary Clinton, Valeant

This is not the first time the pharma industry has drawn the ire of the US presidential hopefuls, but Hilary …

News

LEO Pharma UK/Ireland appoints new dermatology director

March 2, 2016
Medical Communications, Sales and Marketing

LEO Pharma has appointed Michael Hinchy as dermatology director with responsibility for its UK/Ireland affiliate. Michael brings over 16 years …

Appointment
chi_med

Chi-Med starts Phase II trial for thyroid cancer drug

March 2, 2016
Research and Development Chi-Med

Hutchison China MediTech (Chi-Med) says its unit Hutchison MediPharma (HMP) has initiated mid-stage trials for sulfatinib to treat differentiated thyroid …

News
graff_ferring

Ferring names Aaron Graff CEO of US holding company

March 2, 2016
Medical Communications

Swiss fertility treatment company Ferring Pharmaceuticals on Tuesday named Aaron Graff the chief executive of its US unit, Ferring Holding. …

Appointment
merck_innovation_centre

Merck begins late-stage trials of Humira biosimilar

March 2, 2016
Research and Development, Sales and Marketing AbbVie, Humira, Merck, biosimilars

Merck has announced the beginning of a global phase III study of its Humira (adalimumb) biosimilar, MSB11022, in chronic plaque …

News

Wave expands team with new appointments

March 1, 2016
Medical Communications

Medical education specialist, Wave, has made five new appointments, which the company says reflects the growth in its business over …

Appointment
ipsen_logo

Exelixis signs $200 million licensing deal for cancer drug

March 1, 2016
Research and Development, Sales and Marketing Cancer, Cometriq, Exelixis, ipsen

Exelixis has signed a licensing agreement with French biotech firm Ipsen for its cancer drug Cometriq (cabozantinib) for an upfront …

News
celgene_1_02

Two Celgene cancer drugs approved in Ireland

March 1, 2016
Research and Development, Sales and Marketing Abraxane, Cancer, Celgene, Revlimid, imnovid

Irish regulators have recommended two cancer treatments from Celgene: Imnovid (pomalidomide), in combination with dexamethasone, for previously-treated relapsed and refractory …

News
drugs_generic

Delivering successful new drugs

March 1, 2016
Manufacturing and Production, Sales and Marketing AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Pfizer, patents, pharma

Pharma companies are struggling with challenges specific to their industry. Patents for many drugs, that had created massive amounts of …

Feature

The future for pharma packaging

March 1, 2016
Manufacturing and Production distribution, packaging, research, supply chain

The pharmaceutical packaging market is projected for strong growth through 2020, driven by innovation for new products and materials and …

Feature
lupin_pharma_logo

Lupin to set up manufacturing plant in Japan

March 1, 2016
Manufacturing and Production Japan, Lupin, manufacturing

Indian drugmaker Lupin is, via its Japanese unit Kyowa, setting up a manufacturing unit in Japan as part of its …

News
alzheimers

South Florida Uni begins £875,000 dementia drug research programme

March 1, 2016
Manufacturing and Production, Research and Development Alzheimer's

Funding from a consortium worth £875,000 pounds has helped kick start a new dementia drug research program at the University …

News
astellas

Japan approves Astellas hyperphosphatemia drug

March 1, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Astellas, Hyperphosphatemia, Japan, Kiklin

Astellas Pharma has received approval from the Ministry of Health, Labour and Welfare in Japan for a supplemental new drug …

News
valeant_logo_on_board

Valeant shares slide on SEC investigation announcement

March 1, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Philidore, Valeant, regulation

Shares at troubled Valeant plummeted some 20% Monday after the company said it was under investigation by the Securities and …

News

AstraZeneca licenses European rights to constipation drug for $70m

March 1, 2016
Manufacturing and Production, Sales and Marketing AstraZeneca, EU, Japan, Luke Miles, ProStrakan Group, constipation drug, moventig

AstraZeneca said on Tuesday it has agreed to licence rights to its constipation drug Moventig to Japan’s ProStrakan Group for …

News
astrazeneca_plaque

AstraZeneca announces tremelimumab setback in mesothelioma test

March 1, 2016
Manufacturing and Production, Research and Development AstraZeneca, Cancer, MedImmune, tremelimumab

AstraZeneca and its global biologics research and development arm, MedImmune, have announced a setback in the result of their Phase …

News
gensight

GenSight begins Phase III retinal disease trials

February 29, 2016
Research and Development GenSight, Leber’s Hereditary Optic Neuropathy, retinal disease

French biotech GenSight has begun enrolling patients for two parallel pivotal Phase III trials with its lead candidate GS010, a …

News
eli_lilly

CHMP recommends Lilly psoriasis drug for approval

February 29, 2016
Research and Development Eli Lilly, Taltz, psoriasis

Eli Lilly’s Taltz (ixekizumab) has received a positive opinion from the European Medicines Agency’s (EMA) Committee for Medicinal Products for …

News
roche_good

Roche finds contradictory results in identical Phase III asthma trials

February 29, 2016
Manufacturing and Production, Research and Development Roche, lebrikizumab asthma

Roche has reported contradictory results from two identical Phase III studies of lebrikizumab in severe asthma, with one showing the …

News
The Gateway to Local Adoption Series

Latest content

Closing the immunisation gap: partnership working that delivered at scale

June 5, 2026

Phase 2 study explores imaging approach for interstitial lung disease

June 5, 2026

Laverock secures funding for gene-control platform development

June 4, 2026

LifeArc and Elpida partner to advance gene therapies for ultra-rare childhood diseases

June 3, 2026

Well Pharmacy and Alzheimer’s Society launch dementia partnership

June 2, 2026